CEACAM3

CEACAM3 (CGM1a/CD66d) is a granulocyte-expressed immunoglobulin-superfamily receptor that drives opsonin-independent phagocytosis of human-restricted Gram-negative pathogens by directly binding bacterial adhesins, serving as a single-receptor phagocytic and pro-inflammatory module in neutrophils (PMID:8962144, PMID:14707113). Its extracellular domain functions as a direct receptor for gonococcal Opa proteins, mediating bacterial binding and internalization, and engages Neisseria, Moraxella, and Haemophilus species (PMID:8962144, PMID:14707113); functional Opa engagement additionally depends on the alpha-oligosaccharide of bacterial LOS to present the adhesin in a competent conformation (PMID:27376801). Signaling is routed through a cytoplasmic ITAM-like motif (Cyt1 exon) that, upon bacterial engagement, is tyrosine-phosphorylated by Src family kinases—principally at Tyr230—an event required for efficient uptake (PMID:8508798, PMID:11278708, PMID:12864848). The phosphorylated ITAM serves as a docking platform: Vav binds via its SH2 domain to couple the receptor directly to Rac GTP-loading and actin-driven internalization (PMID:14707113, PMID:17339478); Nck binds phospho-CEACAM3 and recruits the WAVE complex to build lamellipodia for engulfment (PMID:22448228); Syk is recruited and is required for the oxidative burst, degranulation, and uptake of large cargo (PMID:17506820); and the PI3K regulatory subunit binds phospho-Tyr230 to drive the oxidative burst and intracellular bacterial killing without being required for uptake itself (PMID:21216968). Signaling is restrained by negative regulators that dock on or downstream of the receptor: the SH2 adaptor Grb14 binds the ITAM (PMID:22948154), the phosphatase PTPRJ directly dephosphorylates CEACAM3's cytoplasmic tyrosines (PMID:35850306), and the Rac-GTP-sequestering protein CYRI-B limits Rac/PAK signaling (PMID:37264948), each constraining phagocytosis and lamellipodia formation. The inflammatory output is mechanistically separable from engulfment: cytokine production requires integration with TLR signaling through a Syk–CARD9–NF-κB axis and the Bcl10 scaffold, whereas engulfment proceeds independently of these factors (PMID:27038042, PMID:28886618).

1. 1993 Medium

   Defined the molecular feature that would make CEACAM3 a signaling receptor by identifying an ITAM-like motif in its cytoplasmic tail, distinguishing it from a non-signaling splice variant.

   Evidence Gene cloning, exon mapping, and splice-variant sequence analysis

   PMID:8508798

   Open questions at the time

   • Motif identified by sequence only, with no functional demonstration at this stage
   • Did not establish which tyrosines are functionally phosphorylated
2. 1996 High

   Established CEACAM3 as a direct cell-surface receptor for bacterial Opa proteins, answering whether neutrophils possess a dedicated adhesin receptor.

   Evidence PMN lysate ligand binding, HeLa transfection with internalization assay, and monoclonal antibody blockade

   PMID:8962144

   Open questions at the time

   • Did not map the binding site within the extracellular domain
   • Downstream signaling not yet defined
3. 1996 Medium

   Showed CEACAM3 (CD66d) crosslinking transmits independent activating signals in neutrophils, raising integrin-mediated adhesion via CD11/CD18.

   Evidence Neutrophil adhesion to HUVEC with CD66 antibodies, CD18 blockade, and calcium chelation

   PMID:8699114

   Open questions at the time

   • Antibody crosslinking does not establish the physiological bacterial trigger
   • Molecular link to integrin upregulation not defined
4. 2001 High

   Demonstrated that the ITAM-like motif is functionally required for phagocytosis and that uptake depends on Syk and PLC, converting a sequence motif into a defined signaling requirement.

   Evidence ITAM tyrosine mutagenesis, DT40 reconstitution, kinase/PLC inhibitors, calcium flux and uptake assays

   PMID:11278708

   Open questions at the time

   • Direct SH2 partners docking on the ITAM not yet identified
   • Connection to actin machinery unresolved
5. 2001 Medium

   Reported a calcium-modulated, phosphorylation-independent association of the cytoplasmic domain with calprotectin and in vitro phosphorylation by multiple kinases.

   Evidence Recombinant cytoplasmic-domain pulldown from granulocyte lysate and in vitro kinase assays

   PMID:11708798

   Open questions at the time

   • Single pulldown without reciprocal validation
   • Functional role of calprotectin binding in phagocytosis not established
   • In vitro kinases may not reflect the in vivo Src-dependent event
6. 2003 High

   Linked Src-family-kinase-dependent tyrosine phosphorylation of CEACAM3 to actin-based uptake, connecting the receptor to the cytoskeleton.

   Evidence ITAM mutagenesis, Src inhibitors, subcellular fractionation, actin staining, and cytochalasin D treatment

   PMID:12864848

   Open questions at the time

   • The actin-nucleating machinery downstream was not identified
   • ITAM-independent residual uptake component left unexplained
7. 2004 High

   Identified Rac GTP-loading as the core actin-regulatory output of CEACAM3 and showed the receptor confers genuine bactericidal capacity across multiple human pathogens.

   Evidence Dominant-negative Rac, Src inhibitors, ITAM mutagenesis, Rac GTP-loading and primary granulocyte killing assays

   PMID:14707113

   Open questions at the time

   • The GEF coupling the ITAM to Rac was not yet identified
   • Distinct from CEACAM6, mechanism of selectivity unresolved
8. 2007 High

   Resolved how CEACAM3 activates Rac by showing Vav binds phospho-Tyr230 directly and is required for Rac loading, establishing a direct ITAM-to-GEF coupling.

   Evidence SH2-phosphopeptide binding, co-IP, Vav1/Vav2-deficient cell rescue, colocalization, and primary granulocyte transduction

   PMID:17339478

   Open questions at the time

   • Other ITAM-docking effectors not yet mapped
   • Quantitative contribution of Vav versus other GEFs unclear
9. 2007 High

   Defined Syk's role at the ITAM as required for microbicidal effector functions and for uptake under demanding cargo/ligand conditions.

   Evidence Co-IP, kinase inhibition, Syk-deficient cells, oxidative burst, degranulation, and killing assays

   PMID:17506820

   Open questions at the time

   • Whether Syk and Vav act in series or parallel not resolved
   • Substrates of Syk in this pathway not enumerated
10. 2011 High

    Separated uptake from killing by showing PI3K binds phospho-Tyr230 and is dispensable for engulfment but required for the oxidative burst and intracellular killing.

    Evidence SH2 binding assay, FRET in intact cells, PI3K inhibitors, ROS and intracellular degradation assays in primary granulocytes

    PMID:21216968

    Open questions at the time

    • Downstream PI3K effectors not identified
    • Mechanism of intracellular killing beyond ROS not detailed
11. 2012 High

    Connected phospho-CEACAM3 to the actin-nucleation machinery via Nck-mediated recruitment of the WAVE complex, explaining lamellipodial engulfment.

    Evidence Co-IP/pulldown, Nck1/2 deletion with rescue, dominant-negative WAVE2, WAVE/Nap1 knockdown, lamellipodia microscopy and uptake assays

    PMID:22448228

    Open questions at the time

    • Coordination between Nck-WAVE and Vav-Rac branches not resolved
    • Spatial hierarchy of effector recruitment unknown
12. 2012 High

    Identified Grb14 as an ITAM-docking negative regulator, establishing that the same phosphomotif recruits both activating and inhibitory adaptors.

    Evidence SH2 microarray screen, co-IP, FRET-FLIM, knockdown and overexpression with uptake assays

    PMID:22948154

    Open questions at the time

    • Mechanism by which Grb14 dampens signaling not defined
    • Competition with activating SH2 effectors not directly measured
13. 2016 High

    Extended CEACAM3 signaling to transcriptional inflammatory output by linking UspA1 engagement to NF-κB via a Syk–CARD9 axis.

    Evidence siRNA of CEACAM3/Syk/CARD9, inhibitors, NF-κB reporter, ChIP, chemokine ELISA, ROS and degranulation assays

    PMID:27038042

    Open questions at the time

    • Did not establish requirement for co-receptor input
    • Intermediate steps between Syk and CARD9 unmapped
14. 2016 Medium

    Showed the bacterial LOS alpha-oligosaccharide is required for Opa to functionally engage CEACAM3, defining a structural prerequisite on the ligand side.

    Evidence HeLa-CEACAM3 uptake and neutrophil chemiluminescence assays with LOS lgtF mutant bacteria

    PMID:27376801

    Open questions at the time

    • No direct binding measurement to confirm conformational model
    • Single lab, functional readouts only
15. 2017 High

    Mechanistically separated the phagocytic and inflammatory arms by showing cytokine production requires TLR co-engagement and Bcl10, while engulfment does not.

    Evidence CEABAC transgenic mice, Rac2/Bcl10/Malt1 knockouts, ex vivo neutrophil infection, cytokine and engulfment assays

    PMID:28886618

    Open questions at the time

    • Molecular nature of TLR-CEACAM3 integration not defined
    • Role of Malt1 left ambiguous
16. 2022 High

    Identified the direct off-switch by demonstrating PTPRJ dephosphorylates CEACAM3 cytoplasmic tyrosines to restrain phagocytosis and lamellipodia.

    Evidence In vitro phosphatase assay on full-length CEACAM3 and phosphopeptides, PTPRJ depletion/overexpression, primary human phagocyte knockdown with lamellipodia and uptake quantification

    PMID:35850306

    Open questions at the time

    • Site preference of PTPRJ on the ITAM not detailed
    • Regulation of PTPRJ recruitment to CEACAM3 unknown
17. 2023 High

    Added a downstream brake by identifying CYRI-B, via a genome-wide screen, as a Rac-GTP sequester that limits CEACAM3 phagocytosis.

    Evidence Genome-wide CRISPR screen, clonal CYRI-B knockout in HL-60, complementation, Rac GTP-loading and PAK phosphorylation assays, uptake assay

    PMID:37264948

    Open questions at the time

    • Whether CYRI-B acts on a CEACAM3-specific Rac pool not resolved
    • Interplay with PTPRJ and Grb14 in signal termination not defined

• How the activating (Vav, Nck-WAVE, Syk, PI3K) and inhibitory (Grb14, PTPRJ, CYRI-B) modules are coordinated in space and time on a single ITAM to set phagocytic threshold versus inflammatory output remains unresolved.
• No integrated structural or kinetic model of competing SH2 effector occupancy
• Stoichiometry and ordering of activating versus inhibitory adaptor recruitment unknown
• Physiological setting that tips the balance between engulfment and cytokine production undefined